Robinson Research Laboratory
Research Focus
Molecular Biology of Melanoma
Funding
Bemis, L.T., Chen,R., Amato,C.M., Robinson,S.E., Classen,E.H., Coffey,D.G., Erickson,P.F. and Robinson,W.A. microRNA-137 Targets Microphthalmia-associated Transcription Factor (MITF) Expression in Melanoma Cell Lines. Cancer Res. 2008;68(5):1362-8.
Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA. Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate. J Cutan Pathol. 2008 Feb;35(2):197-202.
Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA Merkel cell carcinoma: Evaluation of KIT expression. J of Cutaneous Path 34:324-27. 2007
High WA, Robinson WA.Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol.;23:61-79. 2007
Lewis KD, Robinson WA, Millward MJ, et al A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs. 2007 [Epub ahead of print]
Bemis LT, Robinson WA, McFarlane R, et al .EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Lancet Oncol.;8:559-60. 2007
Lab Personnel
William A. Robinson, MD, PhD
Professor
Principle Investigator
Carol Amato, MS
Senior Professional Research Assistant​
Kasey Couts, PhD
Assistant Research Professor
Blair Holman, BS
Research Associate
Morgan Macbeth, BS
Professional Research Assistant​
Robert Van Gulick, BA
Professional Research Assistant